171 related articles for article (PubMed ID: 3913221)
1. [Combined immunosuppression (cyclosporin, azathioprine, methylprednisolone) in patients at immunological risk after kidney transplantation].
Hillebrand G; Castro LA; Illner WD; Schleibner S; Land W; Gurland HJ
Z Urol Nephrol; 1985 Dec; 78(12):667-71. PubMed ID: 3913221
[TBL] [Abstract][Full Text] [Related]
2. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
[TBL] [Abstract][Full Text] [Related]
3. [Results, over a 3-year, period of a triple combination: cyclosporin, azathioprine, prednisolone in high-risk kidney transplants].
Hiesse C; Rieu P; Neyrat N; Charpentier B; Benoit G; Bellamy J; Fries D
Nephrologie; 1987; 8(3):127-9. PubMed ID: 3309700
[TBL] [Abstract][Full Text] [Related]
4. Effective prevention of interstitial rejection crises in immunological high risk patients following renal transplantation: use of high doses of the new monoclonal antibody BMA 031.
Dendorfer U; Hillebrand G; Kasper C; Smely S; Weschka M; Hammer C; Racenberg J; Gurland HJ; Land W
Transplant Proc; 1990 Aug; 22(4):1789-90. PubMed ID: 2389450
[No Abstract] [Full Text] [Related]
5. [Combined basic immunosuppression following kidney transplantation. Cyclosporin A in combination with azathioprine and methylprednisolone].
Land W; Illner WD; Zink RA; Castro LA
MMW Munch Med Wochenschr; 1983 Apr; 125(17):361-3. PubMed ID: 6408461
[No Abstract] [Full Text] [Related]
6. Cyclosporine mono-drug therapy.
Salaman J
Transplant Proc; 1988 Jun; 20(3 Suppl 3):117-20. PubMed ID: 3291223
[TBL] [Abstract][Full Text] [Related]
7. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
8. Renal transplantation in children using cyclosporin A and azathioprine.
Clark AG; Rigden SP; Welsh KI; Bewick M; Koffman G; Haycock GB; Chantler C
Transplant Proc; 1989 Feb; 21(1 Pt 2):1685-6. PubMed ID: 2652552
[No Abstract] [Full Text] [Related]
9. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
[No Abstract] [Full Text] [Related]
10. Compensatory hypertrophy of renal grafts with triple drug therapy.
Ishikawa I; Shikura N; Shinoda A; Fukuda Y; Tsugawa R; Suzuki K
Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):929-32. PubMed ID: 2250411
[TBL] [Abstract][Full Text] [Related]
11. Reduction of immunosuppressive therapy after renal transplantation: a randomized study.
Heering P; Westhoff A; Ivens K; Kutkuhn B; Grabensee B
Transplant Proc; 1994 Oct; 26(5):2530-2. PubMed ID: 7940778
[No Abstract] [Full Text] [Related]
12. Renal allograft immunosuppression. VI. Triple drug therapy versus immunosuppressive double drug combinations: histopathological findings in renal allografts.
Isoniemi H; Krogerus L; von Willebrand E; Taskinen E; Grönhagen-Riska C; Ahonen J; Häyry P
Transpl Int; 1991 Sep; 4(3):151-6. PubMed ID: 1958279
[TBL] [Abstract][Full Text] [Related]
13. [14 years of kidney transplantation in children. Results with special reference to cyclosporin A treatment].
Brodehl J; Pichlmayr R; Offner G
Monatsschr Kinderheilkd; 1985 Oct; 133(10):771-3. PubMed ID: 3906380
[TBL] [Abstract][Full Text] [Related]
14. Does the addition of azathioprine (Aza) to CyA monotherapy after a first rejection prevent a second rejection episode in kidney transplant patients?
Hourmant M; Taupin JL; Leymerigie F; Cantarovich D; Soulillou JP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1589-90. PubMed ID: 2652517
[No Abstract] [Full Text] [Related]
15. [Change from treatment with cyclosporin A to conventional treatment in kidney transplantation].
Matl I; Jirka J; Kocandrle V
Cas Lek Cesk; 1990 Nov; 129(46):1453-6. PubMed ID: 2249245
[TBL] [Abstract][Full Text] [Related]
16. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive protocols at transplantation centers in Turkey.
Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
[No Abstract] [Full Text] [Related]
18. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
Opelz G; Döhler B;
Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
[TBL] [Abstract][Full Text] [Related]
20. Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomized study from 1 to 6 years after transplantation.
Pedersen EB; Hansen HE; Kornerup HJ; Madsen S; Sørensen AW
Nephrol Dial Transplant; 1993; 8(3):250-4. PubMed ID: 8385294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
